Changes in Body Mass Index Over Time in People With and Without HIV Infection.

antiretroviral therapy body mass index cardiovascular disease return to health weight

Journal

Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045

Informations de publication

Date de publication:
Feb 2024
Historique:
received: 12 07 2023
accepted: 01 12 2023
medline: 7 2 2024
pubmed: 7 2 2024
entrez: 7 2 2024
Statut: epublish

Résumé

Excess weight gain is an important health concern among people with HIV (PWH) on antiretroviral therapy (ART). The extent to which ART contributes to body mass index (BMI) changes is incompletely understood. We conducted a retrospective study of PWH initiating ART and demographically matched people without HIV (PWoH). Data on baseline BMI (kg/m The study included 8256 PWH and 129 966 PWoH (mean baseline age, 40.9 and 42.2 years, respectively; 88% men). In adjusted models, the average annual change in BMI in the first 2 years after ART initiation was 0.53 for PWH and 0.12 for PWoH ( PWH initiating ART gained excess weight in the first 2 years, emphasizing the importance of monitoring weight and cardiometabolic health among ART-treated PWH.

Sections du résumé

Background UNASSIGNED
Excess weight gain is an important health concern among people with HIV (PWH) on antiretroviral therapy (ART). The extent to which ART contributes to body mass index (BMI) changes is incompletely understood.
Methods UNASSIGNED
We conducted a retrospective study of PWH initiating ART and demographically matched people without HIV (PWoH). Data on baseline BMI (kg/m
Results UNASSIGNED
The study included 8256 PWH and 129 966 PWoH (mean baseline age, 40.9 and 42.2 years, respectively; 88% men). In adjusted models, the average annual change in BMI in the first 2 years after ART initiation was 0.53 for PWH and 0.12 for PWoH (
Conclusions UNASSIGNED
PWH initiating ART gained excess weight in the first 2 years, emphasizing the importance of monitoring weight and cardiometabolic health among ART-treated PWH.

Identifiants

pubmed: 38323078
doi: 10.1093/ofid/ofad611
pii: ofad611
pmc: PMC10846771
doi:

Types de publication

Journal Article

Langues

eng

Pagination

ofad611

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Déclaration de conflit d'intérêts

Potential conflicts of interest. All authors: No reported conflicts.

Auteurs

Jennifer O Lam (JO)

Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.

Wendy A Leyden (WA)

Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.

Stacey Alexeeff (S)

Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.

Alexandra N Lea (AN)

Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.

Rulin C Hechter (RC)

Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.

Haihong Hu (H)

Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, Rockville, Maryland, USA.

Julia L Marcus (JL)

Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.

Lakecia Pitts (L)

Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.

Qing Yuan (Q)

Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.

William J Towner (WJ)

Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
Department of Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.

Michael A Horberg (MA)

Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.
Mid-Atlantic Permanente Research Institute, Kaiser Permanente Mid-Atlantic States, Rockville, Maryland, USA.

Michael J Silverberg (MJ)

Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.
Department of Epidemiology and Biostatistics, University of California, San Francisco, California, USA.

Classifications MeSH